My investment philosophy focuses on compounding capital at 12-15% annually, prioritizing high-quality, blue-chip companies with wide moats and strong balance sheets. I emphasize concentrated ...

Forbes contributors publish independent expert analyses and insights. I write about investing, markets and Berkshire Hathaway. Berkshire Hathaway’s (BRK/A, BRK/B) Warren Buffett and his late partner ...

Shares of Core Scientific (CORZ), a major player in Bitcoin (BTCUSD) mining and a provider of digital infrastructure for high-performance computing (HPC), surged more than 33% on June 26, following ...

When investors look to find the next big opportunity to invest their capital, they often focus on what's popular at the time or having the best price action in the so-called "popularity contest" that ...

Core Scientific (CORZ) shareholders have rejected a proposed $9 billion all-stock merger with CoreWeave (CRWV), halting one of the most anticipated deals in the AI data center sector. CORZ is higher ...

The veteran industrial components supplier's second quarter fell short of expectations. It missed on both the top and bottom lines for the period. Core & Main, which concentrates on products for ...

Compounding has long been hailed as the "eighth wonder of the world" in wealth creation. However, while most people associate it with stocks or savings, few recognise its immense potential in real ...